May Health

A Modern Approach to Polycystic Ovary Syndrome (PCOS).

Menlo Park, United States · $48.4M raised

Employees
1–10
Business Model
B2B
Total Funding
$48.4M
Last Round
$11.7M Extension RoundMar 2026
Rounds
3

About

May Health is a medical device company developing the Anavi System, a minimally invasive treatment for polycystic ovary syndrome (PCOS) through targeted ovarian ablation. The procedure is designed to lower androgen production and restore ovulation without hormone therapy, administered in an outpatient setting as a one-time treatment. The Anavi System has received CE Mark certification under EU MDR and is currently enrolling patients in the REBALANCE study, a pivotal Investigational Device Exemption (IDE) trial in the United States seeking FDA marketing authorization. May Health operates from its headquarters in Menlo Park, California, with an additional office in Paris, France. The company targets the significant unmet need in PCOS, a common endocrine disorder affecting millions of people of reproductive age worldwide.

Summary

May Health is a Healthcare company based in Menlo Park, United States. It has raised $48.4M in total across 3 rounds, most recently a $11.7M Extension Round round in Mar 2026. Investors include Sofinnova Partners, Trill Impact and Bpifrance.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Extension RoundExtension RoundMar 2026
$11.7M

Sign up to see all 3 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies